The prevalence of hyperglycemia, as a component of the metabolic syndrome, in men of an open population of Siberian city (epidemiological study)

Aim. To determine glucose levels and the prevalence of hyperglycemia, as a component of metabolic syndrome (MS), among men of an open population of 25-64 years of Siberian city.

Material and methods. The study of the prevalence of MS and its components was carried out following a cardiological screening of men aged 25-64 years of Western Siberia city (Tyumen). In order to conduct a single-step epidemiological study using the “random numbers” method, a representative sample of 1000 people was formed among men 25-34, 35-44, 45-54, 55-64 years of Tyumen, the response was 85,2%. Hyperglycemia was taken into account according to the criteria of the metabolic syndrome by NCEPATPIII (2004), IDF (2005), Russian Society of Cardiology (RSC) (2009). The distribution of quantitative parameters in the population was assessed using a percentile analysis.

Results. An average glucose level was established for men of 25-64 years old in Tyumen (4,9±0,8 mmol/l). In participants of 35-44 and 55-64 years, a significant increase in glucose levels was determined. The prevalence of hyperglycemia was 174% according to the same NCEPATP, IDF assessment criteria, 77% — according to the RSC criteria. A consistent age-related trend in the prevalence of hyperglycemia was formed in 3 decades of 25-54 years diapason.

Conclusion. The presented regional features of glucose levels and the prevalence of hyperglycemia should be taken into account when developing a strategy for the prevention of cardiovascular and other non-infectious diseases in Siberian cities.

1. Rodriquez-Colon S, Mo J, Duan Y, et al. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke 2009;40 (1):200-5. doi:10.1161/STROKEAHA.108.523035.

2. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U. S. Diabetes Care 2005;28:2745-9. doi:10.23.2337/diacare.28.11.2745.

3. Mancia G, Вombelli M, Corrao G, et al. Metabolic Syndrome in the PressioniArterioseMonitorate E LoroAssocjazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis. Hypertension 2007;49:40-7. doi:101161/01.HYP.0000251933.22091.24.

4. Mustafina SV, Sherbakova LV, Kozupeeva DA, et al. The prevalence of metabolically healthy obesity: data from the epidemiological suvey in of Novosibirsk. Obesity and metabolism 2018;4:31-7. (In Russ.) doi:10.14341/omet9615.

5. Shlyakhto EV, Konradi AO. Epidemiology of the metabolic syndrome in various regions. Depending on the criteria and prognostic value. Arterial Hypertension. 2007;2 (13):95-112. (In Russ.) doi:10.18705/1607-419X-2007-13-2-95-112.

6. Akimova EV, Gakova EI, Kayumov RH, et al. Some components of metabolic syndrome in young men of Tyumen open population. Siberian Medical Journal (Tomsk). 2011;2 (26):140-3. (In Russ.)

7. Rotar OP, Libis RA, Isaeva EN, et al. Prevalence of metabolic syndrome in cities of Russian Federation. Russ J Cardiol. 2012; (2):55-62. (In Russ.) doi:10.15829/1560-4071-2012-2-55-62.

8. Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010;53 (4):600-5. doi:10.1007/s00125-009-1620-4.

9. Gruzdeva OV, Palicheva EI, Maksimov SA, et al. Metabolic risk factors, as a trigger mechanism of the disease of the cardiovascular system in different age periods in the adult population. Klinicheskaya meditsina. 2017;11:1035-41. (In Russ.) doi:10.18821/0023-2149-2017-95-11-1035-1041.

10. Demkina AE, Boytsov SA. Do fats or carbohydrates shorten our lives? What does the PURE study reveal? Russian Journal of Cardiology. 2018; (6):202-6. (In Russ.) doi:10.15829/15604071-2018-6-202-206.

11. Smirnova NP, Mikhaylova AA. Optimization of regenerative treatment in the elderly patients with dysculatory encephalopathy associated with modifiable risk factors (hypercholesterolemia, hyperglycemia). Journal of New Medical Technologies 2017;3:95-103. (In Russ.) doi:10.1273/article59c4a481ddc7c5.05838022.

12. Nissen SE. US dietary guidelines: an evidence-free zone 2016;164:558-9. doi:10.7326/m16-0035.

13. Akimova EV, Gakova EI, Kayumova MM, et al. Components of the metabolic syndrome and stress in the workplace in men, the urban population. Siberian Medical Journal (Tomsk). 2017;3 (32):959. (In Russ.) doi:10.29001/2073-8552-2017-32-3-95-99.

14. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2002;25:829-34. doi:10.2337/diacare.25.5.829.

15. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.

16. Akimova EV, Akimov AM, Gakova EI, et al. Behavioral risk factors for cardiovascular diseases in men having different work patterns. Profilakticheskaya meditsina. 2016;3:4953. (In Russ.) doi:10.17116/profmed201619349-53.

17. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Russian Journal of Cardiology. 2017; (6):7-85. (In Russ.) doi:10.15829/1560-4071-2017-6-7-85.